MétaCan
Menu
← Retour à la cohorte
Enregistrement W2586708780 · doi:10.1182/blood.v120.21.1944.1944

Higher Proportions of IFNg-Producing T Cells, CD56bright NK Cells and Immature B Cells in the Lymphocytes of G-CSF Stimulated Donor Grafts Are Associated with Less Chronic Gvhd After HSCT: Results From the Canadian BMT Group 0601 Randomized, Phase III Trial

2012· article· en· W2586708780 sur OpenAlexaffabout
Sabine Ivison, Aminia Kariminia, Megan K. Levings, Raewyn Broady, Tony Panzarella, Alisha Albert-Green, Mahmoud Aljurf, Hind Al Humaidan, Ronan Foley, Gerald M. Devins, Holly Kerr, Stephanie J. Lee, David Swajcer, Cynthia L. Toze, Stephen Couban, Kirk R. Schultz

Notice bibliographique

RevueBlood · 2012
Typearticle
Langueen
DomaineMedicine
ThématiqueHematopoietic Stem Cell Transplantation
Établissements canadiensCancerCare ManitobaVancouver General HospitalPrincess Margaret Cancer CentreLeukemia & Lymphoma Society of CanadaQueen Elizabeth II Health Sciences CentreChild and Family Research InstitutePublic Health OntarioHamilton Health SciencesUniversity of TorontoBC Children's Hospital
Organismes subventionnairesnon disponible
Mots-clésMedicineImmunologyGraft-versus-host diseaseBone marrowTransplantationPopulationInternal medicineLymphocyteGastroenterology

Résumé

récupéré en direct d'OpenAlex

Abstract Abstract 1944 Background: The insidious onset and heterogeneous nature of chronic GVHD (cGVHD) impedes its diagnosis and treatment. Donor and graft characteristics, including those which lead to variations in specific cell populations infused at the time of transplantation, may predict the onset of cGVHD. Methods: This study evaluated graft lymphocyte populations of donors enrolled on the prospective Phase III Canadian BMT Group (CBMTG) clinical trial “A Randomized Multicentre Study Comparing G-CSF Mobilized Peripheral Blood and G-CSF Stimulated Bone Marrow in Patients Undergoing Matched Sibling Transplantation for Hematologic Malignancies (CBMTG 0601)”. Proportions of specific lymphocytes in donor grafts were associated with cGVHD in the recipient using logistic regression. Associations were significant if the corresponding p-value was less than 0.05 and the difference between the medians of the two groups was 50% lower than or twice as high as the control. Analyses were performed on G-CSF peripheral blood and bone marrow as a single population due to a data lock on the donor source randomization pending longer follow up. Recipients were considered cGVHD positive if diagnosed with extensive cGVHD and cGVHD negative if free of extensive cGVHD for a minimum of 12 months post transplant. Relapsed recipients and those who died without previous diagnosis of GVHD were excluded from analyses. Cell phenotypes and cytokine production of lymphocytes in the donor grafts were analyzed by flow cytometry in a set of panels that enabled identification of distinct NK, T and B cell subsets. After an initial analysis of 40 samples, a subset of immune populations, which significantly associated with recipient outcome, were analysed in an additional 20 samples. Results: Analyses of cGVHD- vs. cGVHD+ showed the following associations: higher proportions of IFNg-producing T helper cells and CD56bright NK cells in donor grafts were associated with a lack of cGVHD (p<0.005 and p<0.05, respectively). Higher graft proportions of a third population of cells, immature B cells (CD19+IgD−CD27−), were also associated with lack of cGVHD in the recipients (p<0.05). However, a multinomial logistic analysis which divided cGVHD+ outcomes into de novo and cGVHD developing after acute GVHD showed that this cell type actually associated with lack of de novo cGVHD only (see table for details). Conclusions: We have identified an IFNg-producing CD4+ T cell, an NK cell, and an immature B cell population in donor grafts that impact the development of cGVHD in the recipient. CD56bright NK cells are characteristically weakly cytotoxic but efficient producers of IFNg. The protective function of IFNg is supported by previous results from our lab showing that PBMCs of transplant recipients who did not develop cGVHD have higher levels of IFNg mRNA after stimulation (Rozmus et al, 2011). Donor IFNg polymorphisms, as well as graft source (bone marrow vs. peripheral blood), may cause differences in the immune cell proportions of donor grafts. The discovery that immature B cells are associated only with de novo cGVHD lends support to the concept that cGVHD following acute disease may differ biologically from de novo cGVHD. To better understand the role of these cells in disease pathology, more detailed functional assays of these lymphocyte subsets are required. All values are expressed as medians (first – third percentile range). *acute GVHD present, chronic GVHD absent (A+C-) recipients were excluded from the multivariate analyses due to low numbers (n=2). The values are expressed as percentages of the following lymphocytes: CD56bright NK cells; total CD3−, IFNg-producing T cells; total CD3+ and immature B cells; total CD19+. Disclosures: No relevant conflicts of interest to declare.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,002
score de la tête « metaresearch » (Gemma)0,001
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Essai randomisé · Signal consensuel: Essai randomisé
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,015
Score d'incertitude au seuil0,030

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0020,001
Méta-épidémiologie (sens strict)0,0010,000
Méta-épidémiologie (sens large)0,0010,001
Bibliométrie0,0000,000
Études des sciences et des technologies0,0000,001
Communication savante0,0010,000
Science ouverte0,0010,000
Intégrité de la recherche0,0010,002
Charge utile insuffisante (le modèle a refusé de juger)0,0020,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,015
Tête enseignante GPT0,238
Écart entre enseignants0,223 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeEssai randomisé
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2012
Routes d'admission2
Résumé présentoui

Explorer davantage

Même revueBlood→Même sujetHematopoietic Stem Cell Transplantation→Travaux en français237 207→